Jeffrey S. Heier sold $36K of OCUL stock

Jeffrey S. Heier, Chief Scientific Officer of Ocular Therapeutix, Inc (OCUL), sold 3,296 shares of OCUL stock worth $36K, per an SEC Form 4 filed Aug 26, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 24, 2026, 2 days before it was made public.

OCUL has moved -36.5% since the trade date, from $10.78 to $6.85 (Nov 9, 2026 close).